AI can now flag where patients are getting stuck — from enrollment delays to dropped calls — while also enabling new, compliant ways to analyze these interactions at scale. But surfacing the issue is just the first step. When patients are prescribed complex therapies — like specialty drugs, cell and gene treatments, or high-cost biologics […]

Author